Search

Displaying results 7231 - 7240 of 8974 in total
  1. Drug

    Chlorbenzoxamine

    go.drugbank.com/drugs/DB13788
    Experimental

    Categories: Drugs for Functional Gastrointestinal Disorders
  2. Drug

    Idanpramine

    go.drugbank.com/drugs/DB13276
    Experimental

    Categories: Drugs for Functional Gastrointestinal Disorders
  3. Drug

    CMLVAX100

    go.drugbank.com/drugs/DB05164
    Experimental

    It is developed by Breakthrough Therapeutics and has completed phase I of its clinical trial.

  4. Drug

    Afimkibart

    go.drugbank.com/drugs/DB18718
    Investigational

    It is being investigated for ulcerative colitis.

  5. Drug

    Xelaglifam

    go.drugbank.com/drugs/DB21598
    Investigational

    Xelaglifam is under investigation in clinical trial NCT04982705 (IDG-16177 for the Evaluation of Its Safety and Pharmacokinetics). Xelaglifam has a monoisotopic molecular weight of 501.2 Da.

  6. Drug

    TJ003234

    go.drugbank.com/drugs/DB16470
    Investigational

    Categories: Experimental Unapproved Treatments for COVID-19
  7. Drug

    Platycodon grandiflorus leaf

    go.drugbank.com/drugs/DB14356
    Investigational

    Platycodon grandiflorus leaf is a plant/plant extract used in some OTC (over-the-counter) products. It is not an approved drug.

    Mixtures: Elcure Ato
  8. Drug

    Latrunculin B

    go.drugbank.com/drugs/DB08080
    Experimental

    Latrunculin B is a 14-membered macrolide attached to 2-thiazolidinone moiety, isolated from Red Sea sponge _Latrunculia magnifica_.

  9. Drug

    CEQ508

    go.drugbank.com/drugs/DB17911
    Experimental

    Coli Expressing Beta Catenin ShRNA currently being investigated to treat Familial Adenomatous Polyposis.

  10. Drug

    Clesacostat

    go.drugbank.com/drugs/DB18956
    Investigational

    Clesacostat is under investigation in clinical trial NCT04321031 (Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)).